Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 11, 2005
Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter Lindgren, Martin Buxton, Thomas Kahan, et al.
Pharmacoeconomics|April 10, 2009
The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1Peter Lindgren, Martin Buxton, Thomas Kahan, et al.
BMJ Open|February 11, 2014
Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-term outcomes from the CECaT randomised controlled trialHoward Thom, Nicholas E J West, Vikki Hughes, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaSean D Sullivan, Martin Buxton, L Fredrik Andersson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 24, 2005
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force reportScott Ramsey, Richard Willke, Andrew Briggs, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 14, 2006
Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)Linda D Sharples, Matthew Dyer, Fay Cafferty, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 4, 2006
Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trialTony Kendrick, Robert Peveler, Louise Longworth, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK)Linda D Sharples, Fay Cafferty, Nickolaos Demitis, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
A single European currency for EQ-5D health states. Results from a six-country studyWolfgang Greiner, Tom Weijnen, Martin Nieuwenhuizen, et al.
Pageof 4